S. Lopez-Leon

First name

S.

Last name

Lopez-Leon

Williams, R., de Vries, F., Kothny, W., Serban, C., Lopez-Leon, S., Chu, C., & Schlienger, R. (2017). Cardiovascular safety of vildagliptin in patients with type 2 diabetes: A European multi-database, non-interventional post-authorization safety study. Diabetes Obes Metab. http://doi.org/10.1111/dom.12951

View

Williams, R., Kothny, W., Serban, C., Lopez-Leon, S., & Schlienger, R. (2019). Pancreatic safety of vildagliptin in patients with type 2 diabetes mellitus: A European, noninterventional, postauthorization safety study. Endocrinol Diabetes Metab. http://doi.org/10.1002/edm2.52

View

Williams, R., Kothny, W., Serban, C., Lopez-Leon, S., de Vries, F., & Schlienger, R. (2019). Association between vildagliptin and risk of angioedema, foot ulcers, skin lesions, hepatic toxicity, and serious infections in patients with type 2 diabetes mellitus: A European multidatabase, noninterventional, postauthorization safety study. Endocrinol Diabetes Metab. http://doi.org/10.1002/edm2.84

View